Artificial Intelligence in Drug Discovery

Artificial Intelligence in Drug Discovery

blog.benchsci.com/tag/artificial-intelligence-in-drug-discovery
Get knowledge and inspiration to apply artificial intelligence to drug development. Discover startups applying machine learning to biomedical research. Hear how biotech and pharma companies use AI to speed discovery and cut costs. Learn from academic researchers pushing boundaries in applying computation to biology. We interview leaders transforming drug development with data and algorithms. Subscribe now and never miss an episode!


Nick Lynch of the Pistoia Alliance on AI as a Strategic Focus
Aug 7, 2018 • 32 min
On this episode, I speak with Nick Lynch of the Pistoia Alliance ( www.pistoiaalliance.org ), a global nonprofit community of life science stakeholders that works to lower barriers to R&D innovation. A new area of strategic focus is artificial…
Lucas Siow of ProteinQure on AI for Protein-Based Drugs
Aug 7, 2018 • 33 min
On this episode, I speak with Lucas Siow, Head of Business Operations at ProteinQure ( www.proteinqure.com ). ProteinQure uses artificial intelligence and quantum computing to design protein-based drugs such as antibodies and peptides. On this episode,…
Regina Barzilay, AI Small Molecule Discovery and Synthesis
Jul 30, 2018 • 28 min
On this episode, I speak with Regina Barzilay of MIT’s Machine Learning for Pharmaceutical Discovery and Synthesis consortium ( http://mlpds.mit.edu ). Regina is a prolific researcher with many highly cited papers in machine learning. On this episode,…
Tim Guilliams and David Brown, Healx, AI for Rare Diseases
Jul 26, 2018 • 37 min
On this episode, I speak with Tim Guilliams and David Brown of Healx. Healx uses AI to repurpose existing drugs for rare diseases. They claim their approach can bring new treatments to patients 80% faster and 90% cheaper. On this episode, you’ll learn how…
John Cassidy, CEO, Cambridge Cancer Genomics, AI in Oncology
Jul 18, 2018 • 24 min
On this episode, I speak with John Cassidy, CEO of Cambridge Cancer Genomics ( www.ccg.ai ). CCG aims to transform oncology by combining liquid biopsy with genomics and artificial intelligence to predict disease progression and improve treatment. On this…
Kristen Fortney, CEO of BioAge Labs, on AI Aging Research
Jul 10, 2018 • 25 min
On this episode, I speak with Kristen Fortney, founder and CEO of BioAge Labs ( www.bioagelabs.com ). Kristen leads one of just a few companies focused explicitly on aging itself, rather than the diseases for which aging puts people at greater risk. In…
Sam Cooper, CEO of Phenomic AI, on Automated HCS and More
Jun 28, 2018 • 23 min
On this episode, I speak with Sam Cooper, cofounder and CEO of Phenomic AI ( www.phenomic.ai ). Sam and his team use machine learning for automated image analysis to study cell biology and screen drugs. But that’s just the beginning. In this episode,…
Shai Shen-Orr, Chief Scientist, CytoReason, AI in Immunology
Jun 20, 2018 • 31 min
On this episode, I speak with Shai Shen-Orr, cofounder and chief scientist of CytoReason ( www.cytoreason.com ). CytoReason has created a machine learning model of the immune system. This model can integrate data from multiple sources to support drug…
Leila Pirhaji, CEO of ReviveMed, on AI for Metabolomics
Jun 11, 2018 • 28 min
On this episode, I speak with Leila Pirhaji, founder and CEO of ReviveMed ( www.revive-med.com ). ReviveMed uses artificial intelligence to unlock the therapeutic potential of metabolomics. Before learning about ReviveMed, I knew little about…
Mostapha Benhenda of Startcrowd on AI Drug Discovery Hype
May 29, 2018 • 20 min
On this episode, I speak with Mostapha Benhenda of Startcrowd ( http://www.startcrowd.club ). In January, Mostapha wrote a controversial article critiquing several research labs ( https://bit.ly/2qINvQ9 ). Some accused him of using the article just to…
Mauro Cozzi, Researchably, AI for Better Biomedical Search
May 22, 2018 • 30 min
On this episode, I speak with Mauro Cozzi, co-founder of Researchably ( www.researchably.com ). Researchably is a biomedical search engine that uses artificial intelligence to save researchers time—Mauro says up to 90%—searching for scientific papers. I…
Dekel Gelbman, CEO of FDNA, on “Next-Generation Phenotyping”
May 14, 2018 • 30 min
For the inaugural episode of Artificial Intelligence in Drug Discovery, I spoke with Dekel Gelbman, CEO of FDNA ( https://www.fdna.com/ ). FDNA enables precision medicine by using artificial intelligence for next-generation phenotyping. Their technology…